新聞中心
19-12-24
AmCad BioMed in Taiwan placed 7th in Taiwan and 129th in overall A-Pac ranking in the Deloitte Technology Fast 500 ranking. This ranking is one of Asia's most objective rankings for the technology, media and telecommunications (TMT) industries, created to recognize the effort and dedication of the 500 fastest-growing technology companies in Asia Pacific.
AmCad BioMed was recognized for its cutting edge application of AI technology in Ultrasound Image interpretation, driving an outstanding 615% growth rate with its successful go-to-market business models.
Congratulations AmCad!
are the trademarks owned by AmCad in Taiwan and/or in other countries. Unauthorized use of the AmCAD trademarks is prohibited unless specifically authorized.